RATIONALE: Previous studies have demonstrated associations of high ozone levels with increased epidemiologic as well as lung function measures of asthma activity. OBJECTIVES: In an observational study during the summer months, we hypothesized that higher ambient ozone levels are associated with more frequent symptoms, higher airway and systemic inflammation, as well as worse lung function in asthmatics as compared with non-asthmatic individuals. METHODS: Thirty-eight asthmatics and thirteen healthy control subjects residing in metropolitan Atlanta were enrolled during peak ozone season. Medical histories, quality-of-life questionnaires, spirometry, serum immunoglobulin (IgE), peripheral eosinophil counts, and exhaled nitric oxide (NO) were obtained during study visits. Personal ozone exposures over the 2 days before presentation were estimated based on location and activity surveys. MAIN RESULTS: Upper airway symptoms were more frequent in asthmatics. Higher levels of ozone were associated with worse airflow obstruction, lower quality of life scores, greater eosinophilia, and higher exhaled NO levels in asthmatics. Finally, both asthmatics and non-asthmatics with allergies showed associations between air quality and airway inflammation. CONCLUSIONS: In adults with asthma but not controls studied during peak ozone season, increasing ozone exposure predicted lower lung function and increased biomarkers of respiratory and systemic inflammation. These associations were enhanced in atopic participants, both with and without asthma. Importantly, the study findings were noted while atmospheric ozone levels were predominantly within the current and revised national air quality standards.
RATIONALE: Previous studies have demonstrated associations of high ozone levels with increased epidemiologic as well as lung function measures of asthma activity. OBJECTIVES: In an observational study during the summer months, we hypothesized that higher ambient ozone levels are associated with more frequent symptoms, higher airway and systemic inflammation, as well as worse lung function in asthmatics as compared with non-asthmatic individuals. METHODS: Thirty-eight asthmatics and thirteen healthy control subjects residing in metropolitan Atlanta were enrolled during peak ozone season. Medical histories, quality-of-life questionnaires, spirometry, serum immunoglobulin (IgE), peripheral eosinophil counts, and exhaled nitric oxide (NO) were obtained during study visits. Personal ozone exposures over the 2 days before presentation were estimated based on location and activity surveys. MAIN RESULTS: Upper airway symptoms were more frequent in asthmatics. Higher levels of ozone were associated with worse airflow obstruction, lower quality of life scores, greater eosinophilia, and higher exhaled NO levels in asthmatics. Finally, both asthmatics and non-asthmatics with allergies showed associations between air quality and airway inflammation. CONCLUSIONS: In adults with asthma but not controls studied during peak ozone season, increasing ozone exposure predicted lower lung function and increased biomarkers of respiratory and systemic inflammation. These associations were enhanced in atopic participants, both with and without asthma. Importantly, the study findings were noted while atmospheric ozone levels were predominantly within the current and revised national air quality standards.
Authors: P E Tolbert; J A Mulholland; D L MacIntosh; F Xu; D Daniels; O J Devine; B P Carlin; M Klein; J Dorley; A J Butler; D F Nordenberg; H Frumkin; P B Ryan; M C White Journal: Am J Epidemiol Date: 2000-04-15 Impact factor: 4.897
Authors: Clemencia Rodriguez; Russell Tonkin; Jane Heyworth; Merci Kusel; Nick De Klerk; Peter D Sly; Peter Franklin; Tina Runnion; Adrian Blockley; Louis Landau; Andrea L Hinwood Journal: Int J Environ Health Res Date: 2007-10 Impact factor: 3.411
Authors: Steven P Girardot; P Barry Ryan; Susan M Smith; Wayne T Davis; Charles B Hamilton; Richard A Obenour; James R Renfro; Kimberly A Tromatore; Gregory D Reed Journal: Environ Health Perspect Date: 2006-07 Impact factor: 9.031
Authors: Mary B Rice; Petter L Ljungman; Elissa H Wilker; Diane R Gold; Joel D Schwartz; Petros Koutrakis; George R Washko; George T O'Connor; Murray A Mittleman Journal: Am J Respir Crit Care Med Date: 2013-12-01 Impact factor: 21.405
Authors: Michelle L Hernandez; John C Lay; Bradford Harris; Charles R Esther; W June Brickey; Philip A Bromberg; David Diaz-Sanchez; Robert B Devlin; Steven R Kleeberger; Neil E Alexis; David B Peden Journal: J Allergy Clin Immunol Date: 2010-09 Impact factor: 10.793
Authors: Brian D Moore; Dallas Hyde; Lisa Miller; Emily Wong; Jessica Frelinger; Edward S Schelegle Journal: Respiration Date: 2012-04-13 Impact factor: 3.580
Authors: Mark V Avdalovic; Nancy K Tyler; Lei Putney; Susie J Nishio; Sherri Quesenberry; Parmjit J Singh; Lisa A Miller; Edward S Schelegle; Charles G Plopper; Thiennu Vu; Dallas M Hyde Journal: Anat Rec (Hoboken) Date: 2012-08-13 Impact factor: 2.064
Authors: Sasha Bernatsky; Michel Fournier; Christian A Pineau; Ann E Clarke; Evelyne Vinet; Audrey Smargiassi Journal: Environ Health Perspect Date: 2010-09-22 Impact factor: 9.031